Evidence map›Paper›PMID 42303887›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Healthcare contact days in cancer survivors relative to those with no cancer history.

Helen M Parsons, Christina C Newton, Arjun Gupta, W Dana Flanders, Alpa V Patel, Clara Bodelon, Charlie Zhong, J Lee Westmaas, Erika Rees-Punia

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Helen M ParsonsDivision of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA. Pars0100@umn.edu.
Christina C NewtonDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
Arjun GuptaDepartment of Hematology, Oncology and Transplantation, School of Medicine, University of Minnesota, Minneapolis, MN, USA.
W Dana FlandersDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Alpa V PatelDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
Clara BodelonDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
Charlie ZhongDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.
J Lee WestmaasDepartment of Surveillance & Health Equity Science, American Cancer Society, Atlanta, GA, USA.
Erika Rees-PuniaDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer survivors have unique healthcare needs that require frequent contact with the healthcare system to receive cancer-directed treatment and survivorship care. While there is growing evidence of survivors' time burden for cancer care, we have less information about the trajectory of this burden across a broad range of cancers relative to those without cancer.

methodsUsing the Cancer Prevention Study-II Nutrition Cohort linked to Medicare claims from 1999-2017, we describe trajectories of and factors associated with healthcare contact after a cancer diagnosis relative to those without cancer. We use logistic regression to examine the relationship between sociodemographic and cancer characteristics and being in the highest quartile of healthcare contact days.

resultsIn the month of diagnosis the median percentage of days with healthcare contact spiked at 20% compared with 4% among controls and remained higher than controls throughout the year after diagnosis. In the last year of life, cancer cases had a higher median percentage of contact days vs. controls for all months except for the month of death. The highest levels of healthcare contact were among individuals with lung and hematologic cancers, those receiving chemotherapy and/or radiation, older individuals, females, Non-Hispanic White individuals, those with more comorbidities or people living in metropolitan areas.

conclusionWe identify substantial healthcare contact among cancer survivors relative to controls after diagnosis. Our findings can serve as a framework for discussion between providers and patients to inform interventions focused on non-value added healthcare contact across the cancer continuum.

Indexed as

Cancer SurvivorsNeoplasmsAgedAged, 80 and overCohort StudiesFemaleHumansMaleMedicareTime FactorsUnited StatesCancer survivorHealthcare contactTime burden

Identifiers

PMID42303887
PMCPMC13272605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.